D-0784-2021 Class III Terminated
FDA drug recall D-0784-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Aug 20, 2021 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Apr 5, 2022). Affected quantity: 14,544 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 8, 2021
- Initiation Date
- Aug 20, 2021
- Termination Date
- Apr 5, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,544 bottles
Product description
Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90
Reason for recall
Subpotent
Distribution pattern
Product was distributed nationwide.
Code information
Lot # DN120006A, exp. date 12/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0784-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026